MRNA Stock Jumps on CDC's Revised RSV Vaccine Recommendations
The revised recommendations lower the recommended age for RSV vaccination. Now, adults aged 50-59 who are at higher risk of severe illness from the disease are advised to receive a single dose of the vaccine. The previous CDC guidance recommended RSV vaccines for people aged 75 and older, as well as those aged between 60-74 who were at high risk of the disease.
Per the CDC's website, this recommendation was officially adopted last week by the current HHS secretary, Robert F. Kennedy, Jr. Although the CDC director typically accepts or rejects such recommendations, the position is currently vacant, so Kennedy fulfilled that role. President Trump has backed Susan Monarez as his nominee for the post, but her appointment is still pending confirmation by the U.S. Senate.
The broader recommendations come as a surprise because the members of the CDC's advisory committee — who initially made the recommendation earlier this year — were all removed by RFK Jr. last month.
Year to date, the stock has lost 27% compared with the industry's 2% decline.
Image Source: Zacks Investment Research
The expanded CDC recommendations widen Moderna's addressable market for its RSV vaccine, mResvia. By lowering the recommended age group, the guidance opens up a new segment of eligible patients who were previously excluded.
Moderna is one of a handful of companies marketing an RSV vaccine. Though mResvia was initially approved last year for use in people aged 60 and older, the FDA expanded its label last month to include high-risk individuals aged between 18-59.
Despite commercially launching the vaccine last year, mResvia sales were modest as it was approved and recommended later in the contracting season. By that point, many people had already completed their vaccinations with either GSK's GSK Arexvy or Pfizer's PFE Abrysvo.
RSV vaccines gained traction in 2023 with the initial approvals of Arexvy and Abrysvo — the first FDA-approved RSV vaccines. At the time, the CDC issued blanket approvals for use among individuals aged 60 and older. However, the CDC later narrowed that guidance, which trimmed the target market last year. That, combined with the earlier availability of GSK and Pfizer's offerings, gave both companies a dominant position over Moderna.
Both GSK and Pfizer vaccines are already approved for use in individuals aged 60 and older. While GSK's Arexvy is approved for use in high-risk individuals aged 50-59, PFE's Abrysvo is approved for use in high-risk people aged 18-59. The Pfizer vaccine is also approved for use in infants through maternal immunization.
Moderna, Inc. price | Moderna, Inc. Quote
Moderna currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
GSK PLC Sponsored ADR (GSK) : Free Stock Analysis Report
Pfizer Inc. (PFE) : Free Stock Analysis Report
Moderna, Inc. (MRNA) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Trump officials ‘secretly' changed US health data in ‘gender ideology' crackdown, researchers allege
The Trump administration quietly altered massive US health datasets to remove any mention of gender, according to a new analysis. Scientists around the world rely on health data from US government agencies like the Centers for Disease Control and Prevention (CDC). But since President Donald Trump took office in January, these agencies have been altering data labels, mostly without disclosure, according to the investigation published in The Lancet, a leading medical journal. The authors argue that the 'hidden' changes could cast doubt on the integrity of American science. The database edits 'might be politically motivated and [are] not transparent,' Dr Aaron Kesselheim, a professor at Harvard Medical School, and Janet Freilich, a law professor at Boston University, said in the paper. Related Will Trump's funding cuts help Europe lure top research talent from the US? Their analysis included 232 US health datasets that were edited from late January to late March, covering veterans' health care use, global tobacco consumption, stroke deaths, nutrition, exercise, and obesity. It did not include datasets that are updated on a regular basis. About half of these datasets were 'substantially altered' during the two-month period, but only 15 acknowledged that changes had been made, the study found. The parts of the datasets meant for these disclosures remained empty as of early May, the researchers said. In most of the edited datasets – 106 of them – the word 'gender' was swapped out for 'sex'. Related US demands that EU companies comply with anti-diversity order US agencies have not confirmed or explained the changes, but Freilich and Kesselheim suspect they were made to comply with a Trump order to remove 'messages that promote or otherwise inculcate gender ideology'. The executive order, issued on Trump's first day in office, said it aimed to restore 'biological truth' to US agencies, and set a national policy 'to recognise two sexes, male and female,' they said. It was part of a flurry of activity to clamp down on LGBTQ protections. Some data was initially removed from federal websites, but was largely restored due to a court order. Related Trump administration's funding freeze for foreign medical research to hit European scientists The Lancet analysis indicates that not all changes were reversed. It is not clear if the actual numbers were altered, or only the labels about gender or sex. But Freilich and Kesselheim said the distinction is important because some people will respond to surveys differently based on each term. That can undermine the quality of the data and lead researchers to draw inaccurate conclusions, they said. They described the undisclosed changes as a 'crisis' that could make US data 'untrustworthy and unusable'. They called on governments elsewhere in the world to invest in other data sources.
Yahoo
8 hours ago
- Yahoo
Humana Expands Medicaid Footprint With Virginia's Cardinal Care Win
Virginia's Medicaid program, Cardinal Care, has chosen Humana Inc. HUM as one of five insurers to administer services through its new Humana Healthy Horizons plan. All Virginia Cardinal Care members are now eligible to choose this as a new Medicaid plan option. Cardinal Care offers health coverage to low-income individuals, children, seniors, people with disabilities and pregnant women. Rather than paying healthcare providers directly, the program partners with private insurance companies known as Managed Care Organizations, which manage medical services, prescriptions and overall care coordination for members. Humana Healthy Horizons is poised to deliver comprehensive care to individuals and families across the state, focusing not only on physical and mental health but also on the social factors that often hinder better overall well-being. With existing service to Medicare Advantage and TRICARE members in the state, the expansion into Cardinal Care allows Humana to extend its human-centred approach to Medicaid recipients, aiming to offer innovative solutions, address complex needs, and improve both health outcomes and quality of life. This move opens a valuable opportunity for Humana's growth. By managing care for enrolled members, the company can increase memberships and receive regular payments from the state, offering a steady and scalable source of revenue. Through Humana Healthy Horizons, the company already serves 1.5 million Medicaid members in the country. Expanding into Virginia's Medicaid broadens Humana's reach beyond Medicare and TRICARE. In the year-to-date period, Humana's shares have lost 3.9% compared with a 24% decline across the broader industry. Due to rising healthcare costs, increased service utilization, and operational inefficiencies, Humana continues to face pressure on its profitability and long-term margins. Image Source: Zacks Investment Research HUM currently has a Zacks Rank #3 (Hold). Some better-ranked stocks in the medical space areCentene Corporation CNC,Cigna Group CI and Molina Healthcare Inc. MOH,each carrying a Zacks Rank #2(Buy) at present. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. The Zacks Consensus Estimate for Centene's current-year earnings is pegged at $7.28 per share, implying 1.5% year-over-year growth. CNC's earnings surpassed estimates in each of the last three of four quarters, the average surprise being 25.5%. The consensus estimate for Centene's current-year revenues is pegged at $179.5 billion, implying 10.1% year-over-year growth. The Zacks Consensus Estimate for Cigna's current-year earnings is pegged at $29.68 per share, implying 8.6% year-over-year growth. Cigna's earnings surpassed estimates in three of the last four quarters. It has witnessed eight upward revisions in the last 60 days against no movement in the opposite direction. The consensus estimate for Cigna's current-year revenues is pegged at $258.2 billion, implying 4.5% year-over-year growth. The Zacks Consensus Estimate for Molina's current-year earnings is pegged at $28.44 per share, implying 7.9% year-over-year growth. MOH's earnings surpassed estimates in three of the last four quarters. The estimate remained stable in the last 60 days. The consensus estimate for Molina's current-year revenues is pegged at $44.1 billion, implying 8.4% year-over-year growth. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Upturn
9 hours ago
- Business Upturn
Neuro Balance Therapy Update: Strongest Non-Clinical Reflex Routine for Seniors Concerned About Instability
Chicago, July 03, 2025 (GLOBE NEWSWIRE) — Section 1 – Introduction: Reframing Fall Risk in Aging Populations Across the United States, fall-related injuries continue to be a top health concern among older adults. Data from the CDC reveals that one in four Americans aged 65+ experiences a fall each year, with over 800,000 requiring hospitalization. While often attributed to aging, recent biomechanical research highlights deeper underlying causes, including diminished sensory feedback from the feet—an overlooked but significant contributor to instability. With the search for safe, sustainable interventions intensifying, non-invasive options that align with lifestyle accessibility and neuroscience are drawing increased interest. The emergence of nerve-centric balance theories has led to a shift in how wellness providers approach fall prevention. Rather than relying solely on strength-based rehabilitation, newer approaches focus on restoring proprioceptive communication—how the body senses ground contact and responds reflexively to prevent imbalance. These trends are shaping consumer expectations around what it means to stay mobile, strong, and independent while aging. Neuro Balance Therapy is among the programs aiming to meet this demand with targeted, at-home methods based on new understandings of nerve-muscle coordination. To access the full program details and review the educational material, visit the official platform. Section 2 – Neuro Balance Therapy Program Update: Evolution of a Non-Clinical Stability Protocol In alignment with ongoing demand for at-home balance strategies, Neuro Balance Therapy has released a 2025 update to its protocol, reinforcing its educational foundation in proprioceptive activation and nerve-response science. Developed by Certified Balance Specialist Chris Wilson, the program continues to provide structured instruction centered around the stimulation of the deep peroneal nerve —a sensory-motor pathway shown in academic studies to play a critical role in foot reflexes and muscular coordination. Unlike strength-based fitness plans or conventional physiotherapy sessions, Neuro Balance Therapy centers on a simple, time-efficient daily ritual that requires no gym equipment, medication, or clinical oversight. This protocol uses a proprietary 'nerve wake-up' ball designed to apply patterned pressure across the plantar surface of the foot to help retrain dormant nerve endings that contribute to instability. The 2025 update maintains its original DVD format with guided video sequences segmented by progression level—beginner, intermediate, and advanced—while also offering a digital option for increased accessibility. The program is particularly tailored for adults over 60 who may experience heightened fear of falling, previous fall incidents, or early signs of reduced mobility. Program developer Wilson highlights that this expanded reach reflects an effort to ensure that aging adults have a reliable, educational tool to build confidence in movement. Neuro Balance Therapy remains grounded in a non-diagnostic framework and is presented as a supportive lifestyle enhancement based on emerging research in neuromechanics and gerontology. Section 3 – Trend Analysis: Public Concerns, Fall Anxiety, and Rising Interest in Home-Based Prevention Fall prevention has become one of the most searched-for health concerns among adults over 60, particularly those living independently or recovering from injury. A growing body of online discussions reveals a pattern of fear, hesitation, and uncertainty among older individuals—especially those who have experienced falls in the past or live with limited mobility. This trend is reflected not only in medical safety forums and caregiver blogs but also in keyword search data indicating a spike in interest around terms like 'fall-proof exercises,' 'senior balance support,' and 'home remedies for stability.' As mobility-related anxiety grows, consumers are increasingly looking for evidence-based yet low-barrier solutions that can be adopted from home. Rather than focusing solely on strength or endurance, public attention has turned to neuromuscular control—specifically the role of reflexive foot response in preventing unintentional falls. Individuals researching fall risk reduction now frequently encounter terms like 'proprioception,' 'nerve activation,' and 'sensorimotor training' as part of this broader narrative shift. Within this climate of heightened concern and education-seeking behavior, Neuro Balance Therapy has attracted attention for its practical alignment with these needs. Its core premise—that reawakening a dormant foot nerve can reengage natural reflexes and increase stability—reflects the growing interest in nervous system-focused approaches that move beyond traditional exercise or strength-building routines. While not positioned as a replacement for clinical care, the protocol meets a gap in the market where education, self-reliance, and routine movement rituals converge. Further information, including transparency disclosures and instructional methodology, is available through the authorized distribution channel. Section 4 – Spotlight on Proprioceptive Tools and Neuromuscular Activation At the core of the Neuro Balance Therapy protocol is a targeted tool: a specialized spiked ball engineered to stimulate sensory receptors along the sole of the foot. While deceptively simple in appearance, the design is based on emerging studies around tactile feedback and the role of deep nerves in foot stability. The tool is used in a brief 10-second morning ritual to activate what researchers identify as the deep peroneal nerve , which plays a critical role in reflexively engaging foot and lower leg muscles when movement begins or imbalance occurs. The textured surface of the ball is constructed with hardened crystalline polymers—chosen for their ability to provide a consistent, non-compressive stimulus during rolling motions. This form of physical input has been shown in third-party studies to support the re-engagement of sensory-motor pathways that often degrade with age, shoe use, or injury recovery. Rather than functioning as an exercise device, the tool acts as a proprioceptive primer—a method to help the body regain contact awareness with the ground and reestablish neuromuscular timing. This approach draws on insights from evolutionary biomechanics and comparative anthropology, such as those observed in populations accustomed to barefoot mobility. Researchers from Harvard and other institutions have noted that such individuals tend to exhibit stronger foot-ground sensory feedback and lower fall risk later in life—attributed not to strength but to continuous nerve engagement over time. While Neuro Balance Therapy does not claim to treat or diagnose any condition, the inclusion of this tactile tool is aligned with broader wellness trends that seek to improve functional confidence through non-invasive, neuro-supportive interventions. The emphasis on activating rather than strengthening mirrors a shift in how consumers and wellness educators approach stability challenges—one rooted in nervous system health rather than musculoskeletal strain. Section 5 – User Journey Narrative and Market Reception Ongoing online dialogue reveals a clear and consistent theme among older adults concerned with fall-related limitations: the emotional toll of instability often surpasses the physical impact. Reports across support forums and aging wellness platforms reflect a growing frustration with traditional mobility solutions that feel either inaccessible or incomplete. Many express the desire to feel 'safe in their own homes' or to reclaim confidence performing routine tasks without the looming anxiety of a fall. Within this discourse, Neuro Balance Therapy has emerged as a topic of interest, particularly among individuals seeking alternatives to large-scale physical therapy programs or invasive medical options. While individual testimonials are not cited in public releases for compliance reasons, general sentiment within the community has centered on the appeal of the program's simplicity, home-based accessibility, and the perceived novelty of targeting a sensory nerve often overlooked in standard fall prevention plans. The narrative tone of market discussions is often one of cautious optimism. Some describe past experiences with balance training programs that required gym access, heavy equipment, or high mobility thresholds—barriers that left many behind. In contrast, Neuro Balance Therapy is often mentioned as an entry-point protocol: a minimal-commitment routine that offers a sense of daily empowerment and a framework for understanding how balance and stability can be proactively supported without intensive oversight. This emotional connection—between fear, autonomy, and confidence—continues to shape the public reception of fall-prevention solutions. Neuro Balance Therapy's alignment with those concerns, coupled with its non-intimidating delivery format, has contributed to its sustained visibility among aging communities, wellness bloggers, and caregiving resource hubs. Section 6 – Availability and Transparency Statement The complete Neuro Balance Therapy program is currently accessible through the brand's official platform, where consumers can review educational materials and explore the science-backed methodology behind the protocol. The program is offered in both physical and digital formats to accommodate varying technology preferences and household setups. Each version includes access to guided instructional content and the proprietary nerve activation tool central to the protocol's design. All educational content within the program is intended strictly for informational purposes and is presented as a non-clinical, home-based resource. Neuro Balance Therapy does not diagnose or treat medical conditions, and individuals are advised to consult with their healthcare provider before beginning any new wellness regimen. Program components are designed to complement, not replace, broader wellness or physical rehabilitation efforts and are delivered in alignment with current best practices in consumer safety and instructional clarity. Further product details, background information, and transparency disclosures can be found on the official program website. Information about program structure, availability, and research alignment can be found at the official access site. Section 7 – Final Observations and Industry Context The current landscape of fall-prevention solutions reveals an evolving market shaped by demographic trends and wellness consumer expectations. As the population over 60 continues to expand, so does the need for preventative strategies that prioritize accessibility, non-invasiveness, and autonomy. With falls now recognized by public health institutions as both a clinical and lifestyle issue, there is increased scrutiny on programs that promise safety without sustainable, evidence-informed frameworks. Neuro Balance Therapy enters this environment with a measured approach—framing fall prevention not as a fitness goal, but as a daily practice of neurosensory engagement. Its emphasis on proprioceptive restoration, combined with an at-home format, reflects growing demand for solutions that bridge the gap between clinical rehabilitation and consumer-directed wellness. As the industry moves toward greater personalization in health routines, protocols that integrate functional simplicity with research-inspired insights are likely to gain traction. This update also underscores a wider trend: the reframing of mobility and balance not as age-related inevitabilities, but as skillsets that can be reinforced through nerve and muscle coordination. While more longitudinal research is warranted, early public interest in such targeted tools suggests a shift away from generalized exercise programs toward precision-oriented interventions. As balance science continues to develop, Neuro Balance Therapy positions itself as part of the broader movement redefining how older adults interact with their own mobility—through agency, awareness, and the reawakening of long-dormant neuromechanical responses. Section 8 – Public Commentary Theme Summary: Risk Awareness, Independence, and Program Accessibility Public conversations surrounding fall prevention continue to reveal a wide spectrum of experiences and emotions—ranging from fear and frustration to empowerment and cautious hope. A recurring discussion point in online forums and wellness communities is the fear of losing independence due to instability or past fall incidents. Many express concern over the limitations of traditional mobility programs, which often require clinical oversight, frequent appointments, or physical exertion that can feel overwhelming for individuals with existing discomfort or restricted movement. Some have noted the appeal of Neuro Balance Therapy for its non-strenuous routine and minimal space requirements. The fact that the program can be done while seated—without the need for specialized shoes, physical therapy appointments, or weight-bearing movement—has drawn interest among those recovering from injury or living alone. Skepticism also surfaces in certain segments of the discussion. A common question centers on whether a simple nerve-activation ritual could truly make a difference, particularly when contrasted with more robust physical therapy approaches. Others express concern over the proliferation of at-home solutions that appear promising but offer limited scientific transparency. However, the continued referencing of supporting studies on proprioception and deep nerve reflexes helps validate consumer interest and aligns with a trend toward self-education in aging wellness. Overall, public commentary reflects a desire for straightforward, low-barrier entry points into fall-prevention that emphasize autonomy, emotional reassurance, and ease of use. Neuro Balance Therapy's positioning within that dialogue—especially as it avoids over-promising outcomes—has enabled it to retain credibility while encouraging broader conversations about sensory-motor awareness as a foundation for lifelong mobility. About the Company Neuro Balance Therapy is a wellness education program founded with the goal of supporting older adults in regaining stability, confidence, and ease of movement through non-clinical, home-based strategies. Established by Certified Balance Specialist Chris Wilson, the program draws on over a decade of experience in balance instruction and proprioceptive training. Rooted in research-backed methods, Neuro Balance Therapy offers instructional tools designed to help activate underutilized sensory nerves responsible for lower-body coordination. The company's approach reflects a broader commitment to empowering individuals through accessible routines that promote physical self-reliance. Neuro Balance Therapy does not provide treatment or diagnostic services and encourages all users to consult their healthcare provider before beginning any new movement or balance routine. Contact Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
